Patent · US Active

Inhibitors of serine proteases

US7964624B1 · kind B1 · utility

16Cited by
108References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 27, 2007
Grant dateJun 21, 2011
Priority date
Expiry dateAug 6, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K5/06034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I):or a pharmaceutically acceptable salt thereof. These compounds inhibit serine protease, particularly the hepatitis C virus NS3-NS4A protease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.